The time that a drug resides on its target protein has emerged as an important parameter for drug development. A longer drug-target residence time can lead to improved drug efficacy and reduced adverse side effects. However, general strategies for the rational design of drugs with long target residence times are lacking. Here, by experimental and computational characterization of a set of inhibitor-kinase complexes, we show how interactions between inhibitor halogen atoms and protein aromatic residues can increase target residence times. Our results provide a simple strategy for the rational design of inhibitors with prolonged target residence times.
ABSTRACT Prolonged drug residence times may result in longer lasting drug efficacy, improved pharmacodynamic properties and "kinetic selectivity" over off-targets with fast drug dissociation rates. However, few strategies have been elaborated to rationally modulate drug residence time and thereby to integrate this key property into the drug development process. Here, we show that the interaction between a halogen moiety on an inhibitor and an aromatic residue in the target protein can significantly increase inhibitor residence time.
By using the interaction of the serine/threonine kinase haspin with 5-iodotubercidin derivatives as a model for an archetypal active state (type I) kinase-inhibitor binding mode, we demonstrate that inhibitor residence times markedly increase with the size and polarizability of the halogen atom. This key interaction is dependent on the interactions with an aromatic residue in the gate keeper position and we observe this interaction in other kinases with an aromatic gate keeper residue. We provide a detailed mechanistic characterization of the halogen-aromatic π interactions in the haspin-inhibitor complexes by means of kinetic, thermodynamic, and structural measurements along with binding energy calculations. Since halogens are frequently used in drugs and aromatic residues are often present in the binding sites of proteins, our results provide a compelling rationale for introducing aromatic-halogen interactions to prolong drug-target residence times.
Introduction
The kinetics of drug binding have emerged as important parameters in drug development.
A long drug residence time will result in prolonged inhibition after the free drug concentration has dropped due to in vivo clearance, potentially leading to improved drug efficiency and reduced off-target mediated toxicity. In cases where slow off-rates are specific for the target, kinetic selectivity can be achieved over fast off-target dissociation despite similar binding constants (1) . The kinetics of the interaction of a drug with its target are defined by the association rate (kon) and the dissociation rate (koff) constants. For bimolecular interactions, the ratio of these two parameters defines the equilibrium dissociation constant (KD) of a drug, and hence the drug occupancy. Since on-and off-rates are coupled in simple rigid bimolecular interactions, the favorable scenario of fast "on" and slow "off"-rate interactions at a given KD cannot be achieved using this minimalistic binding model. Instead more complex binding models such as induced conformational changes that may trap a ligand in an induced binding pocket are frequently evoked to explain slow binding kinetics.
Kinases are particularly dynamic proteins that provide multiple opportunities for the development of inhibitors that target induced or allosteric binding sites (2) (3) (4) . One of the first kinase inhibitors for which slow dissociation rates have been described is the p38 MAP (mitogen activating protein) kinase inhibitor BIRB-796. This inhibitor binds to an inactive conformation in which the DFG motif is displaced in a so-called "DFG-out" conformation (5) . Inhibitors that bind to this conformation are called type II inhibitors and often have prolonged residence times (τ). However, not all type II inhibitors show slow binding kinetics, suggesting that the DFG-out conformational change per se is not sufficient to explain the slow dissociation rates of BIRB-796 from p38 MAP kinase (6) . Indeed, more recent studies attributed the slow binding kinetics to efficient hydrophobic contacts in the DFG-out pocket, rather than the kinetic dissociation barrier introduced by the DFG-out transition (7) .
However, conformational change has also been evoked as the main mechanism contrib-uting to the slow off-rate of the breast cancer drug lapatinib, a type I inhibitor of the epidermal growth factor receptor (8) .
In addition to protein conformational changes, the rearrangement of water molecules has been discussed as a potential mechanism influencing inhibitor residence time (9) . An example for the influence of water molecules on ligand binding kinetics is the type I CDK inhibitor roniciclib whose slow off-rate is the result of changes in the hydration network coupled to conformational adaptation of the DFG motif (10) . In some cases, the presence of water-shielded hydrogen bonds can also lead to slow dissociation behavior (11) . In addition, reversible covalent inhibitors have recently emerged as an interesting strategy for prolonging target engagement of inhibitors by the interaction of a transient covalent bond between an electrophile and a cysteine residue present in the kinase active site (12) (13) (14) (15) .
Even though protein conformational changes and allosteric pockets can be specifically targeted, they do not offer a straightforward route for ligand design for the modulation of off-rates. Also, the design of reversible covalent interactions requires the presence of cysteine residues in the drug binding site. Many drug receptors, including a large number of kinases, contain cysteines in close proximity to their active sites (16) , but the development of covalent inhibitors may not be feasible for all drug targets. In addition, the introduction of a reactive group into an inhibitor poses additional challenges.
Here, we present data that suggest that interactions mediated by halogens, that are common in drugs, and aromatic residues, that are also typically found in drug binding sites on proteins (17) , can be utilized to design ligands with slow off-rates. We used 5iodotubercidin (5-iTU), a close analogue of the kinase cofactor ATP, as a model inhibitor for a canonical active state kinase binding mode (type I) which does not induced any conformational changes that could contribute to slow inhibitor binding kinetics. Screening against more than 100 diverse kinases showed that an aromatic gatekeeper residue that interacts with the halogen moiety of this inhibitor is required for high affinity binding. We chose haspin, a serine/threonine kinase with known three-dimensional structure (18, 19) , as a model system. Analysis of ligand binding kinetics surprisingly showed that 5-iTU had slow binding kinetics. Mutation of the gatekeeper residue as well as removal or substitution of the iodide with other halogens showed that the slow inhibitor off-rates are due to a -stacking interaction of the halogen with the aromatic gatekeeper. Further studies on a different kinase, cdc2 like kinase (CLK1), showed strong inhibition by 5-iTU, support the generality of our findings. Here, we present structural, biophysical and computational data that strongly suggest that halogen interactions with aromatic residues can be exploited for the development of inhibitors with slow off-rates.
Results and Discussion

5-iTU exhibited slow dissociation rate from haspin
Comparative analysis of the high resolution haspin structures revealed high conservation of the binding modes of both 5-iTU and the nucleoside adenosine ( Fig. 1A-B ). In contrast to adenosine or ATP, which binds with a KD of about 180 μM (19) , 5-iTU showed high affinity for haspin and an unexpectedly long target engagement time. We then further assessed the thermodynamics and kinetics of the binding with ITC (Isothermal Titration Calorimetry), BLI (BioLayer Interferometry) and SPR (Surface Plasmon Resonance) experiments, which consistently confirmed the tight binding with a relatively slow binding kinetics, as measured for instance by BLI (Fig. 1C ). Comparing the binding mode of 5-iTU with that of adenosine, the most striking structural difference between these highly similar molecules was the presence of the iodide moiety which was positioned in close proximity to the F605 gatekeeper forming a halogen-aromatic π interaction ( Fig. 1D ). We therefore hypothesized that this interaction might contribute most of the increase in binding free energy (ΔG) and be responsible for the slow dissociation rate of 5-iTU from haspin.
Preference of 5-iTU for kinases with aromatic gatekeeper
To address our hypothesis, we screened 5-iTU against 137 diverse kinases using temperature shift assays (20) and observed unexpected selectivity of the inhibitor with only 10 kinases exhibiting ΔTm of >5 °C ( Fig. 2A , Table S1 ). Interestingly, analyses of the gatekeeper residues of kinase targets that showed significant temperature shifts and therefore high affinity for 5-iTU, revealed a strong preference for kinases harboring a phenylalanine (Phe) at this position whereas kinases that showed weak interaction (ΔTm 2-5 °C) revealed no preference for a certain residue. This analysis supported our hypothesis that the aromatic gatekeeper is important for high affinity binding ( Fig. 2B ). To confirm these results, we determined the structure of 5-iTU bound to another high affinity target that is structurally very diverse from haspin, CLK1 (ΔTm of 8.6 °C). As expected, the interaction of 5-iTU with CLK1 remarkably resembled that observed in haspin, including the conserved interaction geometry of the iodide with the CLK1 gatekeeper F241. 5-iTU bound CLK1 with high affinity (Kd of ~7 nM by ITC) and slow off-rates estimated to be ~50 mins by BLI ( Fig. 2C -E and Fig. S1 ).
Importance of halogen σ-hole property for halogen-π interaction for slow off-rate Formation of a halogen-π interaction (C-X···π) is driven by the directional positive polarization along the halogen σ-bond with the π molecular orbital of the aromatic system (21) .
However, the main focus of halogen-protein interactions has been on halogen carbonyl/sulphonyl interaction (C-X···O,S bonds) with few examples on the analysis of halogen-aromatic interactions (22) . Because the partial positive charge along the halogen σ-bond diminishes with the size of the halogen, we next substituted the iodide by smaller halogens and characterized the affinities and binding kinetics of these 5-iTU derivatives. Indeed, ITC experiments showed that the affinities of 5-iTU halogen derivatives were reduced with decreasing size of the halogen ( Fig. 3 and Table S2 ).
Removal of the halogen led to a 42-fold decrease in the potency of tubercidin (TU) when compared to that of 5-iTU, and similarly an 8-fold decrease was measured for 5fluorotubercidin (5-fTU). Analyses of the binding kinetics of these five synthesized 5tubercidin halogen derivatives with haspin were performed using three independent techniques: kinetic probe competition assays (kPCA) in solution(23), BLI and SPR using immobilized haspin. Binding affinities determined by these three independent methods correlated well with each other and also with the binding constants determined in solution using ITC ( Fig. 3B ). Dissociation rate constants from all experiments revealed the same behavior with 5-iodide substituted tubercidin displaying the slowest off-rate. The off-rates increased with decreasing halogen size from 5-iodo to 5-fluoro substituted tubercidin and the unsubstituted tubercidin showed the fastest off-rates of binding ( Fig. 3C-D) . However, the absolute values differed somewhat between the different experimental methods used with the residence time ranging from 60 mins (BLI) to 7 mins (SPR) for 5-iTU (SI Appendix, Table S2 and S3). We also observed slower on rates using BLI but not in the SPR experiments. While the general trends were the same in both technologies, the differences in on-and off-rates that have been observed might be due to differences in protein immobilization. As SPR is the more established technology, we used SPR kinetic data for quantitative analysis. The substitution from hydrogen to iodide at the 5 position of TU led to a 48fold increase in the on-rates and 274-fold decrease in the off-rates ( Fig. 3D and SI Appendix, Table S3 ).
Thus, the fast dissociation kinetics observed for 5-fTU coincided with the lack of a pronounced σ-hole in smaller halogens, and hence an inability to form a polar halogen-π interaction with the aromatic gatekeeper. The increase in enthalpically favorable polar interactions of larger halogens was also evident in the calorimetric data that showed a steadily decreasing (more negative) binding enthalpy change from tubercidin to the larger halogens (H < F < Cl < Br < I). This effect of the halogen moieties was supported by the crystal structures showing that despite the highly conserved binding mode of all derivatives, the presence of an additional water in the tubercidin complex within the space adjacent to the gatekeeper created by the removal of larger halogen substituents and the longer distance to the fluoro group, presented suboptimal geometry for direct contacts with F605 in tubercidin and 5-fTU, respectively ( Fig. 3E and SI Appendix, Fig. S2 ).
Importance of aromatic phenylalanine for slow off-rate binding
We next investigated the contributions of the Phe gatekeeper to the binding affinity and the observed slow dissociation kinetics of 5-iTU. Six haspin gatekeeper mutants using amino acids commonly found in kinases were generated, and their affinities against 5-iTU and its halogen-derivatives were analyzed using DSF assays ( Fig. 4A ). As expected, the potency of 5-iTU with the aromatic tyrosine mutant was comparable to wild-type haspin.
For comparison, we analyzed the binding characteristics of 5-iTU with a representative mutant (F605T) in detail. Structural superimposition between the wild-type and the mutant structures (F605Y and F605T) showed that the gatekeeper mutation did not affect the binding mode of 5-iTU, yet led to slight variation of the environment in the pocket. The substitution of the bulky aromatic residue F605 with the small threonine resulted in extension of a water network that filled the expanded binding site in the mutant ( Fig. 4B and SI Appendix, Fig. S3 ). No direct contact was observed between the threonine side chain and the iodide of 5-iTU, although interactions might be mediated through a water bridge. The absence of any strong contact was in agreement with the fast kinetics with ~16-fold lower affinity as demonstrated by SPR ( Fig. 4C-D) . In comparison to the wild-type, the loss of the halogen-π contact in the F605T mutant led to a 6-fold decrease and 8-fold increase in association and dissociation rates, respectively, with the estimated residence time of 5-iTU dramatically dropping to less than a minute ( Fig. 4E and SI Appendix, Table S3 ).
Thermodynamics of halogen-π interactions in slow kinetic behavior
In order to assess the energetic contributions of the halogen-aromatic gatekeeper interaction, we calculated the energy of this interaction using ab initio quantum mechanics and classical methods. The second order Møller-Plesset interaction energies (EMP2) between the inhibitor and the gatekeeper residue correlate well with dissociation rate constants and equilibrium dissociation constants determined experimentally ( Fig. 5A and SI Appendix, Fig. S5 and Tables S6-S9). Partitioning of EMP2 into its constituent energy components using a many-body interaction energy decomposition scheme shows that the major contribution to EMP2 is the correlation energy (ECORR) which describes second-order intermolecular dispersion interactions and the correlation corrections to the Hartree-Fock energy. ECORR increases in magnitude with increasing size of the halogen, corresponding to the decreasing rate of dissociation measured experimentally (Fig. 5B) , and indicating the importance of the halogen interaction with the aromatic gatekeeper for the prolongation of residence times as halogen size increases. The computed ab initio energies also correlate for the interaction of 5-iTU with the F605Y mutant but the magnitude of the interaction energy of 5-iTU with the threonine mutant was underestimated. This discrepancy could be explained by the additional bound water molecule present between 5-iTU and the threonine residue in the F605T structure which was not included in the calculation but would make an energetically favorable contribution to the binding. To account for the complete protein structure in the computation of the binding free energies of the haspin-ligand complexes, we used the classical MMGBSA approach with an implicit solvent model. The computed energies correlate well with calorimetric data measured by ITC, consistent with the increasingly favorable enthalpic contribution to binding as halogen size increases ( Fig. 5C -D and SI Appendix, Table S10 ).
Halogens are frequently found in approved drugs. Interestingly, drug candidates with heavy halogens (Cl, Br, I) perform better in the clinical development pipeline increasing steadily from phase II (44%) to approved drugs (63%) whereas fluorine-containing drug candidates decrease from 56% in phase II to 36.6% in launched drugs (17) . Unfortunately, information on binding kinetics is not available for these molecules but it is tempting to speculate that the presence of halogens may lead to longer lasting drug-protein interactions. A recent survey of the PDB for halogen-protein interactions reported that 33% of all non-bonded interactions (excluding C-X···H contacts) of the heavier halogens in the protein database form aromatic stacking interactions of the C-X···π type (24) . A large number of halogens also interact with backbone carbonyls and thiols and it would be interesting to investigate if these interactions also result in slower ligand binding kinetics. For the selected case of protein kinases, aromatic gatekeeper residues are the most frequently found residue type. Our proposed strategy of incorporating heavier halogens into inhibitors with the goal of increasing target residence time by designing interactions with aromatic residues is a general approach that may lead to active compounds with improved pharmacological properties. The biophysical, structural and computational data presented here on 5-halogen substituted tubercidin derivatives provides a good basis for future studies on this exciting topic. 
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Material and Methods
Protein purification
Haspin and CLK1, both wild-type and all mutants, have been purified as described (18, 25) . Briefly, the recombinant proteins were purified using Co 2+ /Ni 2+ affinity chromatography. For haspin, the His-tagged protein were subsequently purified by size-exclusion chromatography and the final protein was stored in 50 mM HEPES, pH 7.5, 300 mM NaCl, 0.5 mM TCEP. For CLK1, the histidine tag was removed by incubating the protein with TEV protease overnight. The cleaved CLK1 protein was separated by reverse purification on Ni 2+ affinity chromatography, and subsequently size exclusion chromatography. The final CLK1 protein was stored in 30 mM HEPES, pH 7.5, 300 mM NaCl, 50 mM L-Arginine/L-Glutamate mix, 10 mM DTT, 1% glycerol.
Protein crystallization
All crystallization experiments were performed using sitting-drop vapour-diffusion method at 4 °C. For Haspin, the protein at ~12 mg/ml was incubated with 1 mM inhibitors, and the complexed crystals were obtained using the crystallization condition containing 51-63% MPD and 0.1M SPG buffer, pH 6.0-6.5. To obtain the inhibitor-CLK1 complex, apo crystals grew in 20% 1,2-propanediol, 5% glycerol and 0.1 M NaKPO4 were soaked with inhibitor overnight.
Data collection and structure determination
All diffraction data were collected at Diamond Light Source, and processed using MOSFLM (26) . Scaling was performed using aimless from the CCP4 suite (27) . All structures were solved by molecular replacement using Phaser (28) and the deposited CLK1 and haspin structures (PDB entries XYZ and 4OUC respectively) as models. All structures were subjected to one round of automated model building using ARP/wARP (29) , followed by iterative cycles of manual model building in COOT (30), alternated with refinement using REFMAC (31) . TLS definitions used in the final refining rounds were calculated using the TLSMD server (31) . The model quality and geometric correctness of all complexes was verified using MolProbity (32) . Statistics for data collection and structure refinement are summarized in Supplemental Table 11 .
Thermal shift assays
Protein were diluted to 2 µM in a buffer containing 10 mM HEPES, pH 7.5 and 500 mM NaCl, and mixed with SYPRO Orange at 1000-fold dilution of the dye. The inhibitors were added at 10 µM final concentration. The DSF assay was performed using a Real-Time PCR Mx3005p machine (Stratagene) according to the protocol described previously (33) .
Isothermal Titration Calorimetry
All proteins were exchanged into a suitable storage buffer. CLK1 at 100 µM was stored in 20 mM HEPES, pH 7.5, 300 mM NaCl, 50 mM L-arginine/L-glutamate mix and 0.5 mM TCEP. For haspin at 80 µM, the buffer containing 20 mM HEPES, pH 7.5, 250 mM NaCl and 0.5 mM TCEP was used for the wild-type protein, while the gatekeeper mutants were buffer exchanged into 30 mM HEPES, pH 7.5, 400 mM NaCl and 0.5 mM TCEP to increase their stabilities. Calorimetric measurements were carried out using a VP-ITC calorimeter (MicroCal) at 15 °C. For all experiments, the proteins were titrated into the reaction cell containing the compound. Integrated heat of titrations were manually corrected and analysed in Origin. Using a single binding site model, the obtained curve was fitted following a nonlinear least-square minimization algorithm. The binding isotherms and the measured binding enthalpy changes enabled the calculation of entropy changes (T∆S), Gibbs free energy (∆G), the stoichiometry n and Kd.
Biolayer Interference
The binding kinetics were measured by Biolayer Interference method (BLI) using Octet RED384 system (fortéBIO). For haspin, the experiments were performed in the buffer condition containing 20 mM HEPES, pH 7.5, 400 mM NaCl and 0.5 mM TCEP. For CLK1, the same buffer supplemented with 50 mM L-arginine/L-glutamate mix was used. Biotinylated proteins, prepared as previously described, were immobilized on streptavidin biosensors, which were subsequently quenched with L-biotin (34) . The interference patterns of association and dissociation events were measured through a time course of 600 seconds. The binding data were corrected using a double-referencing method, and the kinetics analyses were performed according to the manufacture protocol (fortéBIO).
Surface Plasmon Resonance (SPR)
SPR experiments were performed in HBS-PE+ buffer on a Biacore T200 System (GE Healthcare). Biotinlyated wt and mutant Haspin (50 µg/ml in HBS-P+ buffer) were captured to a SA sensor chip (GE Healthcare) at typical densities of 2-5 kRU using the protocols provided by the manufacturer. Compounds were serially diluted in DMSO and transferred to assay buffer in a 1:100 dilution step to achieve their final test concentrations at a [DMSO] = 1%. For binding analysis, contact times of 60, 120, 240, 300 or 420 seconds were used depending on the kinetics assessed in preliminary tests. Likewise, dissociation times were adjusted to180, 900, 1500 or 3600 seconds, to achieve return of the SPR signals to baseline levels. To obtain kinetic and affinity parameters, sensorgrams (acquired at 10 Hz) were fitted using the BIAevaluation Software (GE Healthcare) to a 1:1 Langmuir model accounting for mass transport limitations. Steady state analysis was performed with the same software using a single site equilibrium binding equation.
Equilibrium und Kinetic probe competition assays (ePCA and kPCA)
ePCA and kPCA experiments were performed in Tris-HCl pH7.5, 150 mM NaCl, 0.01% Tween, 0.01% BSA, 2 mM DTT buffer as previously described for CDK2 in Schiele et al (23) . Biotinylated wt and mutant Haspin (4 nM in assay) were labelled at a molar ratio of 8:1 with SA-Terbium (Cisbio) as TR-FRET donor. Tracers 236 and 199 (Invitrogen) labelled with an Alexa 647 TR-FRET acceptor were respectively used as kinase specific probes at a final concentration of 100 nM.
Compounds were diluted and transferred to Greiner black small volume 384-well microtiter test plates as described (23) . For ePCA, tracer and labeled proteins were dispensed to the ready-to-use compound plates to a final volume of 5 µL and the mixture was incubated for 2 h prior to acquisition of the steady state TR-FRET ratiometric signals (665/620 nm) upon excitation at 337 nm. Normalized values were fitted to a logistic 4-parameter model using the Genedata Screener TM software, and Ki values calculated using the Cheng-Prusoff relationship. For kPCA, the tracer was dispensed to the ready-to-use compound plates prior to introducing them into the PHERAstar FS TM microtiter plate reader. Then the labeled proteins were added to wells to a final volume of 10 µL using the injector system of the instrument, and kinetic TR-FRET readings were made at time zero and every 10 seconds. Blank-subtracted kinetic traces were analyzed with a competitive binding kinetics model using the GraphPad Prism TM software as described (23) .
Prior to compound testing, the steady state affinities of the probes were determined by equilibrium binding titrations (0 to 400 nM) on various Haspin concentrations (0 to 8 nM) with end-point readings of the TR-FRET signals. The probes' association and dissociation kinetics were characterized by titrating them on 4 nM labeled Haspin (0.5 nM SA-Tb) and acquiring the TR-FRET signals in real time. Binding curves were fitted to the corresponding models with Graph Pad Prism TM in order to obtain the affinity and kinetic constants used as parameters in the Cheng-Prusoff and Motulsky and Mahan models.
Quantum mechanical interaction energy calculations
The energy contributions of the inhibitor-aromatic gatekeeper interaction were calculated using ab initio Møller-Plesset perturbation theory to second order (MP2). The Moeller-Plesset perturbation theory improves on the Hartree-Fock method by adding electroncorrelation effects by means of Rayleigh-Schrödinger perturbation theory to different orders (second order in our case). The Protein Preparation wizard of the Maestro program of the Schrodinger suite (Version 2015.r3) was used to pre-process the X-ray crystallographic structures of the haspin-inhibitor complexes, to add missing side chains and to optimize the H-bond network. The impref utility of the Maestro was used for energy minimization using the OPLS3 force field. The impref utility(35) first optimizes position of hydrogen atoms followed by all-atom minimization where non-hydrogen atoms are restrained with a harmonic potential using a force constant of 25 kcal/mol.Å 2 . The coordinates of the inhibitor and the gatekeeper phenylalanine residue were extracted from these energy-minimized structures of haspin-inhibitor complexes. The termini of the phenylalanine residue were blocked with hydrogen atoms and their positions were optimized using the OPLS3 force field in the Maestro program of the Schrödinger suite (36) . In the case of the gatekeeper mutants, the corresponding gatekeeper residues (tyrosine and threonine) were prepared in the same way.
The def2TZVP basis set was used for all calculations and effective core potentials (ECPs) were used for the iodine atom. Ab initio interaction energies at the MP2 level were calculated using the GAMESS software, and partitioned into their constituent interaction energy terms (see Equation 1) using the many body interaction energy decomposition scheme (EDS) described by Góra et al. (37) . In this scheme, the total interaction energy is calculated in a super-molecular approach as the difference between the total energy of a complex (here, of the inhibitor and the gatekeeper residue) and the sum of the energies of its isolated constituents. In all calculations, the complex centered basis set (CCBS) was used consistently and the results are therefore basis set superposition error (BSSE) free due to the full counterpoise correction.
Equation (1)
As shown in Equation 1, the total interaction energy at the MP2 level of theory ( ) includes the components of the Hartree-Fock interaction energy ( ) and the second order refers to the electrostatic multipole component estimated from an atomic multipole expansion, is the electrostatic penetration energy, calculated from the following expression: = -.
Binding free energy calculations
The molecular mechanics-generalized Born surface area (MM/GBSA) method was used to estimate the binding free energy of the inhibitors to haspin kinase. The initial coordinates of the haspin-inhibitor complexes were obtained from the co-crystallized structures (see Supplementary Figure 2 ). The Protein Preparation wizard of the Schrodinger suite (Version 2015.r3) was used for pre-processing of the structures, formation of disulfide bonds, addition of hydrogen atoms and assigning protonation states at pH 7.0. The pmemd module of the Amber14 software suite (38) was used to perform the molecular dynamics (MD) simulations with the ff14SB (39) force field for protein. The LEap module of AmberTools14 was used to construct the topologies of the haspin-inhibitor complexes. The ligand parameters were generated based on the generalized Amber force field (GAFF). To improve the description of charge, dipole moment and geometry of halogenated compounds in molecular mechanics calculations, the positive region ( hole) centered on the halogen atom was represented by an extra-point charge (EP). This inclusion of an EP results in improved modeling of halogen-bonding in MD simulations. The force field parameters for this EP were taken from Ibrahim et al. (40) . For generation of the partial atomic charges for the ligands, the RESP(41) program was used to fit the atom-centered charges to the molecular electrostatic potential (MEP) grid computed by the GAMESS program. The system was centred and aligned with the axes to minimize the volume. The system was then solvated using the TIP3P water model (42) by immersing the protein-ligand complex in a cubic box of water molecules, such that the shortest distance between the edge of the solvation box and the complex is 10 Å. The net charge (-2e) of the system was then neutralized by adding Na + counter ions. For each system, energy minimization was performed in three 1500cycle consecutive runs using the steepest descent minimization method followed by switching to the conjugate gradient method after 500 cycles. Gradually decreasing harmonic restraints with force constants of 500, 1 and 0 kcal/mol.Å 2 were used for non-hydrogen atoms in three consecutive runs. Energy minimization was followed by 1 nanosecond (ns) of gradual heating from 10 K to 300 K with harmonic restraints with a force constant of 50 kcal/mol.Å 2 acting on non-hydrogen atoms. Then the system was equilibrated for 1 ns under NPT conditions at 300K, with heavy atoms (except solvent ions) harmonically restrained with a force constant of 50 kcal/mol.Å 2 . This was followed by an NPT equilibration of 2 ns without any positional restraints. The potential energy function and atomic coordinates were calculated using a 2 femtoseconds (fs) time step. The SHAKE (43) algorithm was used to constrain all the bonds involving hydrogen atoms. The Particle Mesh Ewald (PME) method was used to calculate the electrostatic interactions. A cut-off of 10 Å was set for generating the non-bonded pair list and this pair list was updated every 100 steps. After equilibration, data were collected over a 6 ns simulation run for binding free energy calculations and 3000 sets of atomic coordinates were saved every 2 picoseconds (ps). MM/GBSA calculations of the binding free energy were performed using the MMPBSA.py module implemented in the Amber14 analysis tools. A single-trajectory approach was used in which receptor, ligand and complex geometries were extracted from a single MD trajectory. All the ions and water molecules were stripped from the trajectory snapshots. A salt concentration of 0.15 M and the Born implicit solvent model (igb = 2) were used. Each binding free energy was computed as the sum of a molecular mechanics term (Egas), a Gibbs solvation term (Gsolvation) and an entropic contribution (TSsolute). For the entropic contribution to binding free energy, we computed translational and rotational entropies with a rigid rotor model using the MMPBSA.py module. The calculation of vibrational entropies using normal-mode analysis with MMPBSA.py failed due to the inclusion of the EP in the force field. The free energy of binding for some of the derivatives is positive since vibrational and conformational entropy terms are neglected. The second-order correlation correction energy term (ECORR) for the interaction between the tubercidin derivatives and the gatekeeper residue versus the experimental (SPR) dissociation rate constants (koff) of the tubercidin derivatives This correlation energy (ECORR) includes second-order intermolecular dispersion interactions and the correlation corrections to the Hartree-Fock (HF) energy. C) Second-order Møller-Plesset interaction energy (EMP2) between tubercidin derivatives and gatekeeper residue versus the experimental (ITC) binding affinities (kD) of the tubercidin derivatives. D) Second-order correlation correction energy term (ECORR) for the interaction between the tubercidin derivatives and the gatekeeper residue versus the experimental (ITC) binding affinities (kD) of the tubercidin derivatives. The correlation coefficients (R 2 ) and the linear fits were computed omitting the outlier data points for the F605T mutant. The error bars for the KD (ITC) values are smaller than the size of the data point symbols. Supplemental Table S1 . DSF results for 5-iTU against 137 kinases. All results are listed with decreasing melting temperature shifts (∆Tm). The gatekeeper residues (GK) of the kinases were determined by sequence alignment and analysis of the structures for hits with ∆Tm > 2º. Supplemental Table S3 . Summary of SPR data for haspin wild-type and F605T mutant against tubercidin derivatives 34 Supplemental Table S4 . Solvent accessible surface area of ordered water molecules in the binding pocket. The Solvent Accessible Surface Area (SASA) of water molecules W1-W5 (as shown in Supplemental Figure 3 ), the nitrogen atom of the ε-amino group of K511 (NZ) and the closest C atom of the aromatic ring of F605 (CD1), was obtained by the POPS server, using a probe with 1.4 Å radius (44) . The structures with the halogenated derivatives are compared with the haspin apo-structure (PDB ID: 2WB8). Supplemental Table S8 -Total interaction energy [kcal. mol -1 ] between tubercidin derivatives and gatekeeper Phe 605 residue at consecutively increasing levels of quantum mechanical theory, see equation 1. EEL is the electrostatic energy only, EHL includes the Heitler-London energy, ESCF includes the Hartree-Fock energy as well, and EMP2 is the full Moeller-Plesset second order energy. koff values were measured by SPR and BLI, and KD values were measured by SPR and ITC. The correlation coefficient was calculated only for koff and KD values measured by BLI and ITC, respectively, as there were no SPR data available for the F605Y mutant.
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Supplemental Table S9
Supplemental Table S9 -Contribution of the different interaction energy terms to the total interaction energy, EMP2 [kcal. mol -1 ] between 5-iTU and the gatekeeper residue for the wild type and the two mutants. See equation 1 for the definition of the terms. EEL,MTP is the electrostatic multipole term, EEL,PEN is the penetration electrostatic term, EEX is the exchange term, EDEL is the delocalization term, and ECORR is the correlation energy term. koff values were measured by SPR and BLI, and KD values were measured by SPR and ITC. The correlation coefficient was calculated only for koff and KD values measured by BLI and ITC, respectively, as there were no SPR data available for the F605Y mutant.
37 Supplemental Table S10 Supplemental Table S10 -Binding free energies calculated using the MMGBSA approach for the binding of tubercidin derivatives with haspin. 
Supplemental
